Series - Raising Capital

BIO Partnering™ returns to the San Francisco Marriott Marquis for JPM Week 2027 with enhanced tools to help you identify the right partners, schedule meetings efficiently, and make the most of one of the biotech industry's busiest weeks.

Join this webinar for a guided walkthrough of the BIO Partnering platform, including the latest features designed to simplify partner discovery, streamline meeting scheduling, and help you manage a full week of partnering. You'll also learn how to navigate BIO's onsite meeting space, schedule meetings across multiple locations and stay informed about networking events and activities happening throughout JPM Week.

Whether you're attending for the first time or are a seasoned partnering professional, this session will provide practical tips to set you up for success before you arrive in San Francisco.

During this live webinar, we will cover:
- Overview of BIO Partnering @JPM Week 2027
- Tour of BIO's onsite meeting space at the San Francisco Marriott Marquis
- Best practices for finding partners and scheduling productive meetings
- Live demonstration of the BIO Partnering system
- Tips for managing meetings across multiple JPM Week locations
- Intro to bioRSVP networking events mobile app
- Live Q&A

Learn more about BIO Partnering @JPM Week: https://bpjw.bio.org/ 

Join Senior Vice President, Partnering, Mackensie Knorr for an inside look at BIO Partnering™ @ London Life Sciences Week, BIO’s latest partnering experience taking place during London Life Sciences Week and alongside Jefferies and other key biotech investor and partnering activity across the city. Learn how you can use BIO Partnering to request and schedule strategic meetings and navigate one of the busiest weeks in global biotech partnering.

In this webinar, we will cover:

• What to expect at BIO Partnering @ LLSW
• How to access BIO’s dedicated meeting space at One Aldwych
• A walkthrough of the BIO Partnering system and meeting scheduling
• Tips for building a strong profile and finding the right partners
• Best practices for scheduling and running productive BD meetings during a busy partnering week

About the Series: The Cell and Gene Therapy (CGT) Science Series are seminars focused on scientific topics related to cell and gene therapy products. The CGT Science Series is intended to foster scientific exchange between the Biotechnology Innovation Organization (BIO), the American Society of Cell & Gene Therapy (ASGCT), and FDA’s Center for Biologics Evaluation and Research (CBER) review staff on a variety of topics that span the CGT product lifecycle. The seminars are planned as 60-minute virtual webinars featuring a speaker from one of the three organizations. The CGT Science Series will enable a deep dive into a specific technical and/or scientific area. Topics in the series may include but are not limited to nonclinical, CMC, clinical, or post-market phases of development related to CGT product lifecycle.

In this webinar, Drs. Rombel and Destro will discuss the opportunities where AI/ML can be used to address cell and gene therapy manufacturing bottlenecks, quality issues, and high production costs. The presentation will focus on applying AI/ML in real-world settings to make tangible improvements in process development and manufacturing resulting in fast, reproducible, and cost-effective delivery of cell, gene, and RNA therapies.

This webinar series is co-hosted with ASGCT and the FDA. 

Note: Webinar registration and attendance are limited to BIO members, ASGCT members, and FDA Staff.

​​Join BIO Business Solutions for a two-day webinar series highlighting the latest products, services, and solutions that member companies rely on every day as they prepare for growth.

Each session features concise, 10-minute presentations from trusted BIO Preferred Providers, who will share what's changing across the industry, emerging trends they're seeing, common operational challenges, and new service capabilities. You'll also learn about the exclusive savings and value-added benefits available through your BIO or state association membership.

Whether you're focused on optimizing lab operations, strengthening business functions, or planning for future growth, BIO Savings Week offers practical insights and actionable ideas from partners that support life science companies every day.

Day 2: Scale
Learn about HR, finance, software, compliance, and other business solutions that help organizations scale. Featuring: 

• ADP
• BiotechExec
• Corporate Traveler
• PSC Biotech Corporation
• PSC Software

Walk away with fresh ideas, new resources, and one key takeaway from every partner on what life science companies should be thinking about over the next 12 months.

Join BIO Business Solutions for a two-day webinar series highlighting the latest products, services, and solutions that member companies rely on every day as they prepare for growth. 

Each session features concise, 10-minute presentations from trusted BIO Preferred Providers, who will share what's changing across the industry, emerging trends they're seeing, common operational challenges, and new service capabilities. You'll also learn about the exclusive savings and value-added benefits available through your BIO or state association membership. 

Whether you're focused on optimizing lab operations, strengthening business functions, or planning for future growth, BIO Savings Week offers practical insights and actionable ideas from partners that support life science companies every day. 

Day 1: Build & Operate 

Explore solutions for lab and equipment procurement, facilities, shipping, waste management, and office operations. Featuring:

• Airgas Healthcare
• American Laboratory Trading (ALT)
• SU Group
• UPS Healthcare
• VWR, part of Avantor  

Walk away with fresh ideas, new resources, and one key takeaway from every partner on what life science companies should be thinking about over the next 12 months. 

Join us for a discussion on the current life science investment landscape ahead of London Life Sciences Week and the Jefferies London Healthcare Conference. Hear perspectives from investors and capital markets leaders on where capital is flowing, what they're looking for in companies, and how management teams can prepare for productive business development and financing meetings. 

Gain the insights you need to navigate today's investment landscape, then put them into practice with BIO Partnering @ London Life Sciences Week. Register to connect with investors, biopharma leaders, and potential partners, and start building your meeting schedule. https://llsw.bio.org/ 

Additional speakers will be announced soon—stay tuned for more exciting additions to the lineup.

As monoclonal antibody (mAb) programs approach IND, delays often stem from fragmented development, tech transfer complexity, and limited process efficiency.

In this webinar, Thermo Fisher Scientific presents a reengineered Path to IND for biologics platform that combines advanced platform science with integrated U.S.-based manufacturing to accelerate timelines and reduce risk.

Join our Head of Technical and Scientific Affairs to explore:

• Expanded mAb manufacturing capacity: Future drug substance and product capacity in Plainville, MA to ease constraints and increase availability at sites like Groningen (NL) and Lengnau (CH).
• Advanced CHO-K1 platform with AI/ML: High-performing CHO-K1 cell line and process intensification achieving up to 11 g/L,* and enhanced by AI/ML-driven vector design and clone optimization to boost expression, stability, and speed.
• Accelerated path to IND: End-to-end biologics platform delivering IND-ready material in as little as 8 months with titer levels of up to 8 g/L.*
• Integrated process characterization and validation: Risk-based approach to PC, PV, and tech transfer to strengthen process robustness and help to accelerate PPQ readiness.
• Risk-mitigated development approach: Combines QbD, stage-gate governance, and qualified scale-down models to help to reduce variability and enable more predictable scale-up.
• Flexible scale model: Single-use bioreactor strategy (500–5,000 L) across a global network to streamline tech transfer from development through commercial manufacturing.

Discover how integrating advanced cell line engineering, high-efficiency processes, and a unified U.S. manufacturing strategy can help bring your mAb therapy to IND faster—with greater control and confidence.

​Join Dr. Wallace Lin for an overview of programming and activities at BIO Asia Taiwan 2026. BIO Partnering's Samuel Marquez will provide an introduction to the BIO Partnering™ system, as well as a demo to get you started.

Learn more and register at https://bioasiataiwan.com/

The Advanced Research Projects Agency for Health (ARPA-H) advances bold, innovative research to solve the most challenging health problems. Their programs span from fundamental science to translational medicine, driving breakthrough discoveries that transform patient care and public health outcomes. ARPA-H makes pivotal investments in breakthrough technologies and broadly applicable platforms, capabilities, resources, and solutions with the potential to transform important areas of medicine and health that cannot readily be accomplished through traditional research or commercial activity. ARPA-H solutions aim to benefit everyone. 

View this webinar to learn more about the ARPA-H Small Business Program, its research and funding programs, and opportunities for engagement featuring ARPA-H’s Small Business Program Portfolio Manager, Sam Gussman-Toh. 

This webinar is appropriate for companies at all stages of development who are interested in partnering with ARPA-H to bring their ideas to life. Topics covered include: 

• Funding opportunities, including those for small businesses 
• ARPA-H’s Small Business Innovation Research (SBIR) awards and Small Business Technology Transfer (STTR) solicitation 
• Engagement opportunities for industry, academia, government, and early adopters